Rieux-Laucat F - Search Results

1

Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients.

Neven B, Bruneau J, Stolzenberg MC, Meyts I, Magerus-Chatinet A, Moens L, Lanzarotti N, Weller S, Amiranoff D, Florkin B, Bader-Meunier B, Leverger G, Ferster A, Chantrain C, Blanche S, Picard C, Molina TJ, Brousse N, Durandy A, Rizzi M, Bossuyt X, Fischer A, Rieux-Laucat F. Neven B, et al. Blood. 2014 Sep 4;124(10):1597-609. doi: 10.1182/blood-2014-02-553834. Epub 2014 Jun 26. Blood. 2014. PMID: 24970930 Free article.

2

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP. Rieux-Laucat F, et al. Science. 1995 Jun 2;268(5215):1347-9. doi: 10.1126/science.7539157. Science. 1995. PMID: 7539157

3

Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.

DiSanto JP, Rieux-Laucat F, Dautry-Varsat A, Fischer A, de Saint Basile G. DiSanto JP, et al. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9466-70. doi: 10.1073/pnas.91.20.9466. Proc Natl Acad Sci U S A. 1994. PMID: 7937790 Free PMC article.

4

Around the V(D)J recombinase machinery.

de Villartay JP, Rieux-Laucat F, Fischer A. de Villartay JP, et al. Res Immunol. 1994 Feb;145(2):151-4; discussion 155-8. doi: 10.1016/s0923-2494(94)80030-8. Res Immunol. 1994. PMID: 8079049 Review. No abstract available.

5

Normal T cell receptor V beta usage in a primary immunodeficiency associated with HLA class II deficiency.

Rieux-Laucat F, Le Deist F, Selz F, Fischer A, de Villartay JP. Rieux-Laucat F, et al. Eur J Immunol. 1993 Apr;23(4):928-34. doi: 10.1002/eji.1830230425. Eur J Immunol. 1993. PMID: 8096185

6

Lack of selective V beta deletion in peripheral CD4+ T cells of human immunodeficiency virus-infected infants.

Bahadoran P, Rieux-Laucat F, Le Deist F, Blanche S, Fischer A, de Villartay JP. Bahadoran P, et al. Eur J Immunol. 1993 Aug;23(8):2041-4. doi: 10.1002/eji.1830230850. Eur J Immunol. 1993. PMID: 8102102

7

Clinical, immunological, and pathological consequences of Fas-deficient conditions.

Le Deist F, Emile JF, Rieux-Laucat F, Benkerrou M, Roberts I, Brousse N, Fischer A. Le Deist F, et al. Lancet. 1996 Sep 14;348(9029):719-23. doi: 10.1016/S0140-6736(96)02293-3. Lancet. 1996. PMID: 8806292

8

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

Benkerrou M, Le Deist F, de Villartay JP, Caillat-Zucman S, Rieux-Laucat F, Jabado N, Cavazzana-Calvo M, Fischer A. Benkerrou M, et al. Eur J Immunol. 1997 Aug;27(8):2043-7. doi: 10.1002/eji.1830270831. Eur J Immunol. 1997. PMID: 9295043

9

Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?

de Villartay JP, Rieux-Laucat F, Fischer A, Le Deist F. de Villartay JP, et al. Springer Semin Immunopathol. 1998;19(3):301-10. doi: 10.1007/BF00787227. Springer Semin Immunopathol. 1998. PMID: 9540158 Review. No abstract available.

10

Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome.

Rieux-Laucat F, Bahadoran P, Brousse N, Selz F, Fischer A, Le Deist F, De Villartay JP. Rieux-Laucat F, et al. J Clin Invest. 1998 Jul 15;102(2):312-21. doi: 10.1172/JCI332. J Clin Invest. 1998. PMID: 9664072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters